Upsized and target-topping Bay Area biotech IPO scores $252M

The South San Francisco company is the seventh life sciences IPO from the region in a year when there has yet to be a Wall Street debut by a native Bay Area tech company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.